Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials
Despite several decades of research into treatments for patent ductus arteriosus (PDA), there is continued uncertainty regarding whether, when, and how best to treat PDA and the long-term consequences. There are almost 5000 babies enrolled into clinical trials, but the questions remain largely unans...
Main Authors: | Juszczak, E, Gupta, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2018
|
Similar Items
-
Transport and Anaesthesia Consideration for Transcatheter Patent Ductus Arteriosus Closure in Premature Infants
by: Tuan Chen Aw, et al.
Published: (2023-09-01) -
Efficacy of Repeated Courses of Ibuprofen in the Closure of Patent Ductus Arteriosus in Premature Infants
by: Ting-An Yen
Published: (2017-02-01) -
Artificial Intelligence-Based Diagnostic Support System for Patent Ductus Arteriosus in Premature Infants
by: Seoyeon Park, et al.
Published: (2024-04-01) -
Early or Late Surgical Ligation of Medical Refractory Patent Ductus Arteriosus in Premature Infants
by: Chien-Chou Hsiao, et al.
Published: (2009-01-01) -
Trial of selective early treatment of patent ductus arteriosus with ibuprofen
by: Gupta, S, et al.
Published: (2024)